Acquisition by David Roberts of 741 shares of LeMaitre Vascular at 100.74 subject to Rule 16b-3
| LMAT Stock | USD 85.60 1.24 1.47% |
Slightly above 53% of LeMaitre Vascular's private investors are presently thinking to get in. The analysis of overall sentiment of trading LeMaitre Vascular stock suggests that some investors are interested at this time. LeMaitre Vascular's investing sentiment can be driven by a variety of factors including economic data, LeMaitre Vascular's earnings reports, geopolitical events, and overall market trends.
Filed transaction by LeMaitre Vascular Director, Officer: President And Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Read at macroaxis.com
LeMaitre Vascular Fundamental Analysis
We analyze LeMaitre Vascular's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LeMaitre Vascular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LeMaitre Vascular based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
LeMaitre Vascular is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
LeMaitre Vascular Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LeMaitre Vascular stock to make a market-neutral strategy. Peer analysis of LeMaitre Vascular could also be used in its relative valuation, which is a method of valuing LeMaitre Vascular by comparing valuation metrics with similar companies.
Peers
LeMaitre Vascular Related Equities
| OFIX | Orthofix Medical | 13.46 | ||||
| INFU | InfuSystems Holdings | 3.76 | ||||
| ATRC | AtriCure | 3.27 | ||||
| LKFN | Lakeland Financial | 0.26 | ||||
| UTMD | Utah Medical | 0.11 | ||||
| MMSI | Merit Medical | 1.04 | ||||
| PAHC | Phibro Animal | 2.03 | ||||
| KRMD | Repro Med | 2.96 |
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.